Surgical Infections· 2017Q2· Guideline
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
- 573citations
- Q2SCImago
- 2017year
Short summary
The Surgical Infection Society (SIS) has released updated evidence-based guidelines for managing intra-abdominal infections (IAI), incorporating literature published since 2008 and using the GRADE system for evidence and recommendation strength.
AI-generated from the title and abstract; the full text is not read.
Key points
- Updated SIS guidelines for intra-abdominal infection (IAI) management are based on literature primarily from 2008 onwards.
- Recommendations are evidence-based and graded using the GRADE system for evidence quality and recommendation strength.
- Key areas addressed include risk assessment, source control, and antimicrobial therapy (timing, selection, duration).
- The guidelines also provide approaches for patients who fail initial therapy and specific recommendations for pediatric IAI cases.
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND: Previous evidence-based guidelines on the management of intra-abdominal infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and 2010. At the time the most recent guideline was released, the plan was to update the guideline every five years to ensure the timeliness and appropriateness of the recommendations. METHODS: Based on the previous guidelines, the task force outlined a number of topics related to the treatment of patients with IAI and then developed key questions on these various topics. All questions were approached using general and specific literature searches, focusing on articles and other information published since 2008. These publications and additional materials published before 2008 were reviewed by the task force as a whole or by individual subgroups as to relevance to individual questions. Recommendations were developed by a process of iterative consensus, with all task force members voting to accept or reject each recommendation. Grading was based on the GRADE (Grades of Recommendation Assessment, Development, and Evaluation) system; the quality of the evidence was graded as high, moderate, or weak, and the strength of the recommendation was graded as strong or weak. Review of the document was performed by members of the SIS who were not on the task force. After responses were made to all critiques, the document was approved as an official guideline of the SIS by the Executive Council. RESULTS: This guideline summarizes the current recommendations developed by the task force on the treatment of patients who have IAI. Evidence-based recommendations have been made regarding risk assessment in individual patients; source control; the timing, selection, and duration of antimicrobial therapy; and suggested approaches to patients who fail initial therapy. Additional recommendations related to the treatment of pediatric patients with IAI have been included. SUMMARY: The current recommendations of the SIS regarding the treatment of patients with IAI are provided in this guideline.
The authors' abstract, as published at the source. Surgical Infections, 2017 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Emergency Medicine
Emergency MedicineMedicine